基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 医药中间体 杂环化合物 ARV-766
  • Luxdegalutamide (ARV-766)

Luxdegalutamide (ARV-766)

新品
Luxdegalutamide (ARV-766)
询价 10mg 起订
50mg 起订
100mg 起订
浙江 更新日期:2026-09-11

杭州埃米尔生物技术有限公司

VIP1年
联系人:沈忠
电话:19011298796拨打
手机:19011298796 拨打
邮箱:17816380947@139.com

产品详情:

英文名称:
Luxdegalutamide (ARV-766)
CAS号:
2750830-09-0
品牌:
EMERTH
产地:
Hangzhou
保存条件:
-4°C, sealed storage, away from moisture
纯度规格:
98%
产品类别:
PROTACs
Imported:
Yes
use:
For Research Use Only (RUO)
Product Specifications:
CAS No.: 2750830-09-0; Molecular Formula: C₄₅H₅₄FN₇O₆; Molecular Weight: 807.95 g/mol; Purity: ≥98%; Appearance: White to off-white solid; Solubility: DMSO
Target:
Androgen Receptor (AR)

Product Description — Luxdegalutamide (ARV-766)

Luxdegalutamide (ARV-766), also known as JSB462, is a potent, orally bioavailable androgen receptor (AR)-targeted PROTAC (Proteolysis-Targeting Chimera) protein degrader. Its chemical name is 4-(4-((1-(4-(((1R,3R)-3-(4-cyano-3-methoxyphenoxy)-2,2,4,4-tetramethylcyclobutyl)carbamoyl)phenyl)piperidin-4-yl)methyl)piperazin-1-yl)-N-((S)-2,6-dioxopiperidin-3-yl)-2-fluorobenzamide. Luxdegalutamide is designed to induce proximity between the androgen receptor and the Cereblon (CRBN) E3 ubiquitin ligase, promoting ubiquitination and subsequent proteasomal degradation of AR. This targeted degradation mechanism makes ARV-766 a valuable research compound for studying AR signaling, protein degradation pathways, and AR-driven cancer biology.

Product Specifications: CAS No. 2750830-09-0; molecular formula C₄₅H₅₄FN₇O₆; molecular weight 807.95 g/mol. Luxdegalutamide has been investigated as an AR degrader capable of targeting wild-type AR as well as clinically relevant AR ligand-binding-domain mutations, including L702H, H875Y, and T878A. It can therefore be used as a research tool in studies of androgen receptor signaling, AR mutation-associated resistance mechanisms, targeted protein degradation, and prostate cancer models.

Usage & Precautions: Luxdegalutamide is intended for research use only and is not intended for human or veterinary use, diagnosis, treatment, or prevention of disease. Researchers should handle the compound according to appropriate laboratory safety procedures and consult the product-specific SDS and Certificate of Analysis (COA) before use. The compound is reported to be insoluble in water and ethanol and soluble in DMSO; actual solubility may vary depending on experimental conditions. Store the product according to the conditions specified on the product label or COA and protect it from moisture, excessive heat, and direct light. Appropriate personal protective equipment (PPE), including gloves, protective clothing, and eye protection, should be used during handling.


PROTAC;AR degrader;Prostate Cancer;Drug Discovery;

公司简介

杭州埃米尔生物技术有限公司位于浙江省杭州市钱塘区下沙街道安和药谷,立足杭州生物医药产业集聚区位优势,专注深耕ADC/XDC 生物偶联技术研发服务、医药小分子中间体定制合成两大核心业务,是聚焦抗体偶联药物上下游研发配套的专业化生物技术初创企业,面向药企、CRO 公司、高校科研院所提供从工艺开发、样品合成到质控分析的一站式技术外包解决方案。

成立日期 (1年)
注册资本 200万人民币
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,试剂,定制,服务
主营行业 合成材料中间体,生物技术服务,技术培训服务,整体实验外包服务

Luxdegalutamide (ARV-766)相关厂家报价

  • ARV-766
  • ARV-766
  • 上海杰瑞兴生物医药科技有限公司 VIP
  • 2026-09-24
  • 询价
内容声明
拨打电话 立即询价